Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1989 Aug 19;299(6697):477–479. doi: 10.1136/bmj.299.6697.477

Effect of salcatonin given intranasally on early postmenopausal bone loss.

K Overgaard 1, B J Riis 1, C Christiansen 1, M A Hansen 1
PMCID: PMC1837347  PMID: 2507027

Abstract

OBJECTIVE--To study the effect of salmon calcitonin (salcatonin) given intranasally on calcium and bone metabolism in early postmenopausal women. DESIGN--Double blind, placebo controlled, randomised group comparison. SETTING--Outpatient clinic for research into osteoporosis. SUBJECTS--52 Healthy women who had had a natural menopause two and a half to five years previously. INTERVENTIONS--The 52 women were allocated randomly to two years of treatment with either salcatonin 100IU given intranasally (n = 26) or placebo (n = 26). Both groups received a calcium supplement of 500 mg daily. Seven of the women receiving salcatonin and six of those receiving placebo left the study before its end. MAIN OUTCOME MEASURES--Bone mineral content in the spine, the total skeleton, and the forearms after two years of treatment. RESULTS--Bone mineral content in the spine was significantly higher in the women who had received salcatonin than in those who had received placebo both after one year and after two years of treatment. After one year the difference was 3.8% (95% confidence interval 0.0 to 7.6%) and after two years it was 8.2% (3.8 to 12.6%). In contrast, the bone mineral content in the distal and proximal forearms and in the total skeleton declined similarly in both groups by about 2% each year, and after two years of treatment the differences between the groups were not significant. Biochemical estimates of bone turnover were not affected by salcatonin. CONCLUSION--The results suggest that salcatonin given intranasally in the dose used prevents bone loss in the spine of early post menopausal women but does not affect the peripheral skeleton.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Christiansen C., Christensen M. S., McNair P., Hagen C., Stocklund K. E., Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest. 1980 Aug;10(4):273–279. doi: 10.1111/j.1365-2362.1980.tb00033.x. [DOI] [PubMed] [Google Scholar]
  2. Civitelli R., Gonnelli S., Zacchei F., Bigazzi S., Vattimo A., Avioli L. V., Gennari C. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest. 1988 Oct;82(4):1268–1274. doi: 10.1172/JCI113725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  4. Genant H. K., Cann C. E., Ettinger B., Gordan G. S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982 Nov;97(5):699–705. doi: 10.7326/0003-4819-97-5-699. [DOI] [PubMed] [Google Scholar]
  5. Gotfredsen A., Borg J., Christiansen C., Mazess R. B. Total body bone mineral in vivo by dual photon absorptiometry. I. Measurement procedures. Clin Physiol. 1984 Aug;4(4):343–355. doi: 10.1111/j.1475-097x.1984.tb00809.x. [DOI] [PubMed] [Google Scholar]
  6. Greenberg C., Kukreja S. C., Bowser E. N., Hargis G. K., Henderson W. J., Williams G. A. Effects of estradiol and progesterone on calcitonin secretion. Endocrinology. 1986 Jun;118(6):2594–2598. doi: 10.1210/endo-118-6-2594. [DOI] [PubMed] [Google Scholar]
  7. Gruber H. E., Ivey J. L., Baylink D. J., Matthews M., Nelp W. B., Sisom K., Chesnut C. H., 3rd Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism. 1984 Apr;33(4):295–303. doi: 10.1016/0026-0495(84)90187-2. [DOI] [PubMed] [Google Scholar]
  8. Johansen J. S., Mølholm Hansen J. E., Christiansen C. A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol (Copenh) 1987 Mar;114(3):410–416. doi: 10.1530/acta.0.1140410. [DOI] [PubMed] [Google Scholar]
  9. Kiel D. P., Felson D. T., Anderson J. J., Wilson P. W., Moskowitz M. A. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987 Nov 5;317(19):1169–1174. doi: 10.1056/NEJM198711053171901. [DOI] [PubMed] [Google Scholar]
  10. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  11. MacIntyre I., Stevenson J. C., Whitehead M. I., Wimalawansa S. J., Banks L. M., Healy M. J. Calcitonin for prevention of postmenopausal bone loss. Lancet. 1988 Apr 23;1(8591):900–902. doi: 10.1016/s0140-6736(88)91712-6. [DOI] [PubMed] [Google Scholar]
  12. Nilas L., Borg J., Gotfredsen A., Christiansen C. Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med. 1985 Nov;26(11):1257–1262. [PubMed] [Google Scholar]
  13. Nilas L., Hassager C., Christiansen C. Long-term precision of dual photon absorptiometry in the lumbar spine in clinical settings. Bone Miner. 1988 Mar;3(4):305–315. [PubMed] [Google Scholar]
  14. Nilas L., Nørgaard H., Pødenphant J., Gotfredsen A., Christiansen C. Bone composition in the distal forearm. Scand J Clin Lab Invest. 1987 Feb;47(1):41–46. [PubMed] [Google Scholar]
  15. Overgaard K., Riis B. J., Christiansen C., Pødenphant J., Johansen J. S. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol (Oxf) 1989 Apr;30(4):435–442. doi: 10.1111/j.1365-2265.1989.tb00443.x. [DOI] [PubMed] [Google Scholar]
  16. Pødenphant J., Larsen N. E., Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta. 1984 Sep 15;142(1):145–148. doi: 10.1016/0009-8981(84)90110-4. [DOI] [PubMed] [Google Scholar]
  17. Reginster J. Y., Denis D., Albert A., Deroisy R., Lecart M. P., Fontaine M. A., Lambelin P., Franchimont P. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet. 1987 Dec 26;2(8574):1481–1483. doi: 10.1016/s0140-6736(87)92619-5. [DOI] [PubMed] [Google Scholar]
  18. Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. doi: 10.1172/JCI110039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Riis B. J., Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med. 1988 Apr;84(4):646–653. doi: 10.1016/0002-9343(88)90099-x. [DOI] [PubMed] [Google Scholar]
  20. Riis B. J., Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med. 1988 Apr;84(4):646–653. doi: 10.1016/0002-9343(88)90099-x. [DOI] [PubMed] [Google Scholar]
  21. Riis B. J., Thomsen K., Christiansen C. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? Calcif Tissue Int. 1986 Sep;39(3):128–132. doi: 10.1007/BF02555107. [DOI] [PubMed] [Google Scholar]
  22. Riis B., Thomsen K., Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med. 1987 Jan 22;316(4):173–177. doi: 10.1056/NEJM198701223160401. [DOI] [PubMed] [Google Scholar]
  23. Selby P. L., Peacock M. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women. Clin Endocrinol (Oxf) 1986 Nov;25(5):543–547. doi: 10.1111/j.1365-2265.1986.tb03607.x. [DOI] [PubMed] [Google Scholar]
  24. Stevenson J. C., Abeyasekera G., Hillyard C. J., Phang K. G., MacIntyre I., Campbell S., Lane G., Townsend P. T., Young O., Whitehead M. I. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause. Eur J Clin Invest. 1983 Dec;13(6):481–487. doi: 10.1111/j.1365-2362.1983.tb00133.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES